Brief: Invivo Therapeutics Reports Q2 Loss Per Share Of $7.48
Aug 7 (Reuters) - InVivo Therapeutics Holdings Corp
NVIV.O :
* INVIVO THERAPEUTICS REPORTS 2018 SECOND QUARTER FINANCIAL
RESULTS
* Q2 LOSS PER SHARE $7.48
Source text for Eikon: ID:nBw7QVYm9a
Further company coverage: NVIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InVivo Therapeutics Holdings
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Dorian LPG, Apple
U.S. STOCKS ON THE MOVE-CMS Energy, SunPower, Etsy
InVivo Therapeutics falls on filing for Chapter 11 bankruptcy
Brief: InVivo Therapeutics Holdings Received Notice Of Delisting Or Failure To Satisfy Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Alibaba, Cisco, CRISPR